Fluctuations in Parkinson's disease: progress and challenges

Lancet Neurol. 2024 May;23(5):448-449. doi: 10.1016/S1474-4422(24)00116-9. Epub 2024 Mar 15.

Authors

Francisco Cardoso¹, Eduardo Tolosa²

Affiliations

¹ Movement Disorders Unit, Neurology Service, Internal Medicine Department, The Federal University of Minas Gerais, Belo Horizonte 30150-290, Brazil. Electronic address: fecardosoc@gmail.com.
² Institut d'Investigacions Biomediques August Pi i Sunyer, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Barcelona, Spain.

PMID: 38499016
DOI: 10.1016/S1474-4422(24)00116-9

No abstract available

MeSH terms

Antiparkinson Agents
Humans
Levodopa
Parkinson Disease*

Substances

Antiparkinson Agents
Levodopa